Pubblicazioni

Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia

2024 - THE NEW ENGLAND JOURNAL OF MEDICINE

Auchus, Richard J; Hamidi, Oksana; Pivonello, Rosario; Bancos, Irina; Russo, Gianni; Witchel, Selma F; Isidori, Andrea M; Rodien, Patrice; Srirangalingam, Umasuthan; Kiefer, Florian W; Falhammar, Henrik; Merke, Deborah P; Reisch, Nicole; Sarafoglou, Kyriakie; Cutler, Gordon B; Sturgeon, Julia; Roberts, Eiry; Lin, Vivian H; Chan, Jean L; Farber, Robert H

COVID-19 pandemic and adrenals: deep insights and implications in patients with glucocorticoid disorders

2023 - ENDOCRINE

Cozzolino, Alessia; Hasenmajer, Valeria; Newell-Price, John; Isidori, Andrea M

Effects of Dual-Release Hydrocortisone on Bone Metabolism in Primary and Secondary Adrenal Insufficiency: A 6-Year Study

2023 - JOURNAL OF THE ENDOCRINE SOCIETY

Hasenmajer, Valeria; Ferrari, Davide; De Alcubierre, Dario; Sada, Valentina; Puliani, Giulia; Bonaventura, Ilaria; Minnetti, Marianna; Tomaselli, Alessandra; Pofi, Riccardo; Sbardella, Emilia; Cozzolino, Alessia; Gianfrilli, Daniele; Isidori, Andrea M

Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection

2020 - THE LANCET DIABETES & ENDOCRINOLOGY

Isidori, A. M.; Pofi, R.; Hasenmajer, V.; Lenzi, A.; Pivonello, R.

Mortality data from the European Adrenal Insufficiency RegistryâPatient characterization and associations

2018 - CLINICAL ENDOCRINOLOGY

Quinkler, M.; Ekman, B.; Zhang, P.; Isidori, A. M.; Murray, R. D.